Brd4

protein-coding gene in the species Rattus norvegicus

Uses your system voice; voice and rate in settings.

≈ 14 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

  • DeutschBrd4
  • EnglishBrd4bromodomain containing 4
  • EspañolBrd4
  • FrançaisBrd4
  • NederlandsBrd4
  • PortuguêsBrd4
  • srnBrd4
  • SvenskaBrd4

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Gene location (Human)
Chr.Chromosome 19 (human)[1]
Band19p13.12Start15,235,519 bp[1]
End15,332,545 bp[1]
Gene location (Mouse)
Chr.Chromosome 17 (mouse)[2]
Band17 B1|17 17.39 cMStart32,196,274 bp[2]
End32,284,722 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • buccal mucosa cell

  • sural nerve

  • tendon of biceps brachii

  • nipple

  • internal globus pallidus

  • pylorus

  • secondary oocyte

  • cardia

  • renal medulla

  • vena cava
Top expressed in
  • Rostral migratory stream

  • genital tubercle

  • tail of embryo

  • cumulus cell

  • blood

  • zygote

  • internal carotid artery

  • ascending aorta

  • secondary oocyte

  • aortic valve
More reference expression data
BioGPS


More reference expression data
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

23476

57261

Ensembl

ENSG00000141867

ENSMUSG00000024002

UniProt

O60885

Q9ESU6

RefSeq (mRNA)

NM_014299
NM_058243
NM_001330384
NM_001379291
NM_001379292

NM_001286630
NM_020508
NM_198094

RefSeq (protein)

NP_001317313
NP_055114
NP_490597
NP_001366220
NP_001366221

NP_001273559
NP_065254
NP_932762

Location (UCSC)Chr 19: 15.24 – 15.33 MbChr 17: 32.2 – 32.28 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Bromodomain-containing protein 4 is a protein that in humans is encoded by the BRD4 gene.[5][6]

BRD4 is a member of the BET (bromodomain and extra terminal domain) family, which also includes BRD2, BRD3, and BRDT.[7] BRD4, similar to other BET family members, contains two bromodomains that recognize acetylated lysine residues.[8] BRD4 also has an extended C-terminal domain with little sequence homology to other BET family members.[7]

Structure

edit edit source

The two bromodomains in BRD4, termed BD1 and BD2, consist of 4 alpha-helices linked by 2 loops.[9] The ET domain structure is made up of 3 alpha-helices and a loop.[10] The C-terminal domain of BRD4 has been implicated in promoting gene transcription through interaction with the transcription elongation factor P-TEFb and RNA polymerase II.[11][12][13]

Function

edit edit source

The protein encoded by this gene is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human BRD2 (RING3) protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. This gene has been implicated as the chromosome 19 target of translocation t(15;19)(q13;p13.1), which defines the NUT midline carcinoma. Two alternatively spliced transcript variants have been described.[6]

Role in cancer

edit edit source

Most cases of NUT midline carcinoma involve translocation of the BRD4 gene with NUT genes.[14] BRD4 is often required for expression of Myc and other "tumor driving" oncogenes in hematologic cancers including multiple myeloma, acute myelogenous leukemia and acute lymphoblastic leukaemia.[15]

BRD4 is a major target of BET inhibitors,[15][8] a class of pharmaceutical drugs currently being evaluated in clinical trials.

Interactions

edit edit source

Notably, BRD4 interacts with P-TEFb via its P-TEFb interaction domain (PID), thereby stimulating its kinase activity and stimulating its phosphorylation of the carboxy-terminal domain (CTD) of RNA polymerase II.[11]

BRD4 has been shown to interact with GATA1,[16] JMJD6,[17] RFC2,[18] RFC3,[18] RFC1,[18] RFC4[18] and RFC5.[18]

BRD4 has also been implicated in binding with the diacetylated Twist protein, and the disruption of this interaction has been shown to suppress tumorigenesis in basal-like breast cancer.[19]

BRD4 has also been shown to interact with a variety of inhibitors, such as MS417; inhibition of BRD4 with MS417 has been shown to down-regulate NF-κB activity seen in HIV-associated kidney disease.[20] BRD4 also interacts with apabetalone (RVX-208), which is being evaluated for treatment of atherosclerosis and cardiovascular disease.[21]

References

edit edit source
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000141867 – Ensembl, May 2017 Wikipedia revision 1359419719, retrieved 2026-11-21
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000024002 – Ensembl, May 2017 Wikipedia revision 1359419719, retrieved 2026-11-21
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine. Wikipedia revision 1359419719, retrieved 2026-11-21
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine. Wikipedia revision 1359419719, retrieved 2026-11-21
  5. ^ Dey A, Ellenberg J, Farina A, Coleman AE, Maruyama T, Sciortino S, et al. (September 2000). "A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition". Molecular and Cellular Biology. 20 (17): 6537–6549. doi:10.1128/MCB.20.17.6537-6549.2000. PMC 86127. PMID 10938129. Wikipedia revision 1359419719, retrieved 2026-11-21
  6. ^ a b "Entrez Gene: BRD4 bromodomain containing 4". Wikipedia revision 1359419719, retrieved 2026-11-21
  7. ^ a b Zeng L, Zhou MM (February 2002). "Bromodomain: an acetyl-lysine binding domain". FEBS Letters. 513 (1): 124–128. Bibcode:2002FEBSL.513..124Z. doi:10.1016/s0014-5793(01)03309-9. PMID 11911891. S2CID 29706103. Wikipedia revision 1359419719, retrieved 2026-11-21
  8. ^ a b Shi J, Vakoc CR (June 2014). "The mechanisms behind the therapeutic activity of BET bromodomain inhibition". Molecular Cell. 54 (5): 728–736. doi:10.1016/j.molcel.2014.05.016. PMC 4236231. PMID 24905006. Wikipedia revision 1359419719, retrieved 2026-11-21
  9. ^ Devaiah BN, Singer DS (1 January 2013). "Two faces of brd4: mitotic bookmark and transcriptional lynchpin". Transcription. 4 (1): 13–17. doi:10.4161/trns.22542. PMC 3644036. PMID 23131666. Wikipedia revision 1359419719, retrieved 2026-11-21
  10. ^ Wu SY, Chiang CM (May 2007). "The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation". The Journal of Biological Chemistry. 282 (18): 13141–13145. doi:10.1074/jbc.r700001200. PMID 17329240. Wikipedia revision 1359419719, retrieved 2026-11-21
  11. ^ a b Itzen F, Greifenberg AK, Bösken CA, Geyer M (July 2014). "Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation". Nucleic Acids Research. 42 (12): 7577–7590. doi:10.1093/nar/gku449. PMC 4081074. PMID 24860166. Wikipedia revision 1359419719, retrieved 2026-11-21
  12. ^ Jonkers I, Lis JT (March 2015). "Getting up to speed with transcription elongation by RNA polymerase II". Nature Reviews. Molecular Cell Biology. 16 (3): 167–177. doi:10.1038/nrm3953. PMC 4782187. PMID 25693130. Wikipedia revision 1359419719, retrieved 2026-11-21
  13. ^ Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K, et al. (August 2005). "Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4". Molecular Cell. 19 (4): 535–545. doi:10.1016/j.molcel.2005.06.029. PMID 16109377. Wikipedia revision 1359419719, retrieved 2026-11-21
  14. ^ French CA (June 2010). "Demystified molecular pathology of NUT midline carcinomas". Journal of Clinical Pathology. 63 (6): 492–496. doi:10.1136/jcp.2007.052902. PMID 18552174. S2CID 2200842. Wikipedia revision 1359419719, retrieved 2026-11-21
  15. ^ a b Da Costa D, Agathanggelou A, Perry T, Weston V, Petermann E, Zlatanou A, et al. (July 2013). "BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia". Blood Cancer Journal. 3 (7): e126. doi:10.1038/bcj.2013.24. PMC 3730202. PMID 23872705. Wikipedia revision 1359419719, retrieved 2026-11-21
  16. ^ Lamonica JM, Deng W, Kadauke S, Campbell AE, Gamsjaeger R, Wang H, et al. (May 2011). "Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes". Proceedings of the National Academy of Sciences of the United States of America. 108 (22): E159–68. doi:10.1073/pnas.1102140108. PMC 3107332. PMID 21536911. Wikipedia revision 1359419719, retrieved 2026-11-21
  17. ^ Liu W, Ma Q, Wong K, Li W, Ohgi K, Zhang J, et al. (December 2013). "Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release". Cell. 155 (7): 1581–1595. doi:10.1016/j.cell.2013.10.056. PMC 3886918. PMID 24360279. Wikipedia revision 1359419719, retrieved 2026-11-21
  18. ^ a b c d e Maruyama T, Farina A, Dey A, Cheong J, Bermudez VP, Tamura T, et al. (September 2002). "A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase". Molecular and Cellular Biology. 22 (18): 6509–6520. doi:10.1128/MCB.22.18.6509-6520.2002. PMC 135621. PMID 12192049. Wikipedia revision 1359419719, retrieved 2026-11-21
  19. ^ Shi J, Wang Y, Zeng L, Wu Y, Deng J, Zhang Q, et al. (February 2014). "Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer". Cancer Cell. 25 (2): 210–225. doi:10.1016/j.ccr.2014.01.028. PMC 4004960. PMID 24525235. Wikipedia revision 1359419719, retrieved 2026-11-21
  20. ^ Zhang G, Liu R, Zhong Y, Plotnikov AN, Zhang W, Zeng L, et al. (August 2012). "Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition". The Journal of Biological Chemistry. 287 (34): 28840–28851. doi:10.1074/jbc.M112.359505. PMC 3436579. PMID 22645123. Wikipedia revision 1359419719, retrieved 2026-11-21
  21. ^ McLure KG, Gesner EM, Tsujikawa L, Kharenko OA, Attwell S, Campeau E, et al. (31 December 2013). "RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist". PLOS ONE. 8 (12) e83190. Bibcode:2013PLoSO...883190M. doi:10.1371/journal.pone.0083190. PMC 3877016. PMID 24391744. Wikipedia revision 1359419719, retrieved 2026-11-21

Further reading

edit edit source edit edit source PDB gallery
  • 2oss: Crystal structure of the Bromo domain 1 in human Bromodomain Containing Protein 4 (BRD4)
  • 2ouo: Crystal Structure of the Bromo domain 2 in human Bromodomain Containing Protein 4 (BRD4)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1359419719 under CC BY-SA 4.0; modifications have been made.

Words in each sectionFurther readingFurther readingFurther reading: 778 words778InteractionsInteractionsInteractions: 158 words158FunctionFunctionFunction: 86 words86Role in cancerRole in cancerRole in cancer: 75 words75StructureStructureStructure: 72 words72
Words in each section. Measured from the stored article body; sections below the minimum are not plotted.

Provenance

snapshot brd4-2743302-699bd8eea7795ea1 · hash 699bd8eea7795ea1469232eb3914b1172667458e506464228073c2e411bb8f35 · captured 2026-06-15 · ledger · version history

Cite this page as: encyclopegia.org, “Brd4”, snapshot brd4-2743302-699bd8eea7795ea1. https://encyclopegia.org/a/brd4